125 related articles for article (PubMed ID: 35709525)
21. Circular RNA hsa_circ_0000745 may serve as a diagnostic marker for gastric cancer.
Huang M; He YR; Liang LC; Huang Q; Zhu ZQ
World J Gastroenterol; 2017 Sep; 23(34):6330-6338. PubMed ID: 28974900
[TBL] [Abstract][Full Text] [Related]
22. Tissue and plasma thioredoxin reductase expressions in patients with glioblastoma multiforme.
Kemerdere R; Kacira T; Hanimoglu H; Kucur M; Tanriverdi T; Canbaz B
J Neurol Surg A Cent Eur Neurosurg; 2013 Jul; 74(4):234-8. PubMed ID: 23512591
[TBL] [Abstract][Full Text] [Related]
23. H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer.
Chen JS; Wang YF; Zhang XQ; Lv JM; Li Y; Liu XX; Xu TP
Neoplasma; 2016; 63(2):223-30. PubMed ID: 26774144
[TBL] [Abstract][Full Text] [Related]
24. Thioredoxin System Protein Expression Is Associated with Poor Clinical Outcome in Adult and Paediatric Gliomas and Medulloblastomas.
Yao A; Storr SJ; Al-Hadyan K; Rahman R; Smith S; Grundy R; Paine S; Martin SG
Mol Neurobiol; 2020 Jul; 57(7):2889-2901. PubMed ID: 32418115
[TBL] [Abstract][Full Text] [Related]
25. Downregulated Expression of linc-ROR in Gastric Cancer and Its Potential Diagnostic and Prognosis Value.
Yu X; Ding H; Shi Y; Yang L; Zhou J; Yan Z; Xiao B
Dis Markers; 2020; 2020():7347298. PubMed ID: 33163123
[TBL] [Abstract][Full Text] [Related]
26. A five-microRNA panel in plasma was identified as potential biomarker for early detection of gastric cancer.
Zhu C; Ren C; Han J; Ding Y; Du J; Dai N; Dai J; Ma H; Hu Z; Shen H; Xu Y; Jin G
Br J Cancer; 2014 Apr; 110(9):2291-9. PubMed ID: 24595006
[TBL] [Abstract][Full Text] [Related]
27. Long non-coding RNA UCA1 may be a novel diagnostic and predictive biomarker in plasma for early gastric cancer.
Gao J; Cao R; Mu H
Int J Clin Exp Pathol; 2015; 8(10):12936-42. PubMed ID: 26722487
[TBL] [Abstract][Full Text] [Related]
28. Serum angiopoietin-like protein 2 as a potential biomarker for diagnosis, early recurrence and prognosis in gastric cancer patients.
Toiyama Y; Tanaka K; Kitajima T; Shimura T; Imaoka H; Mori K; Okigami M; Yasuda H; Okugawa Y; Saigusa S; Ohi M; Inoue Y; Mohri Y; Goel A; Kusunoki M
Carcinogenesis; 2015 Dec; 36(12):1474-83. PubMed ID: 26420253
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of serum tRF-23-Q99P9P9NDD as a potential biomarker for the clinical diagnosis of gastric cancer.
Zhang Y; Gu X; Qin X; Huang Y; Ju S
Mol Med; 2022 Jun; 28(1):63. PubMed ID: 35690737
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of both thioredoxin reductase and glutathione reductase may contribute to the anticancer mechanism of TH-302.
Li S; Zhang J; Li J; Chen D; Matteucci M; Curd J; Duan JX
Biol Trace Elem Res; 2010 Sep; 136(3):294-301. PubMed ID: 19838642
[TBL] [Abstract][Full Text] [Related]
31. Hsa_circ_0065149 is an Indicator for Early Gastric Cancer Screening and Prognosis Prediction.
Shao Y; Tao X; Lu R; Zhang H; Ge J; Xiao B; Ye G; Guo J
Pathol Oncol Res; 2020 Jul; 26(3):1475-1482. PubMed ID: 31432324
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of circulating miR-21 and miR-222 as diagnostic biomarkers for gastric cancer.
Emami SS; Nekouian R; Akbari A; Faraji A; Abbasi V; Agah S
J Cancer Res Ther; 2019; 15(1):115-119. PubMed ID: 30880765
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic Sensitivity of NLR and PLR in Early Diagnosis of Gastric Cancer.
Fang T; Wang Y; Yin X; Zhai Z; Zhang Y; Yang Y; You Q; Li Z; Ma Y; Li C; Song H; Shi H; Zhang Y; Yu X; Gao H; Sun Y; Xie R; Xue Y
J Immunol Res; 2020; 2020():9146042. PubMed ID: 32211444
[TBL] [Abstract][Full Text] [Related]
34. Identification of circulating microRNAs as novel potential biomarkers for gastric cancer detection: a systematic review and meta-analysis.
Zhu X; Lv M; Wang H; Guan W
Dig Dis Sci; 2014 May; 59(5):911-9. PubMed ID: 24337687
[TBL] [Abstract][Full Text] [Related]
35. Circulating long non-coding RNA PCGEM1 as a novel biomarker for gastric cancer diagnosis.
Jiang H; Guo S; Zhao Y; Wang Y; Piao HY; Wu Y; Zhang J
Pathol Res Pract; 2019 Oct; 215(10):152569. PubMed ID: 31421977
[TBL] [Abstract][Full Text] [Related]
36. Nesfatin-1 is a potential diagnostic biomarker for gastric cancer.
Wang XQ; Zheng Y; Fang PF; Song XB
Oncol Lett; 2020 Feb; 19(2):1577-1583. PubMed ID: 31966083
[TBL] [Abstract][Full Text] [Related]
37. A thioredoxin reductase and/or thioredoxin system-based mechanism for antioxidant effects of ambroxol.
Huang J; Xu J; Tian L; Zhong L
Biochimie; 2014 Feb; 97():92-103. PubMed ID: 24103200
[TBL] [Abstract][Full Text] [Related]
38. Three-dimensional combined biomarkers assay could improve diagnostic accuracy for gastric cancer.
Sun L; Tu H; Chen T; Yuan Q; Liu J; Dong N; Yuan Y
Sci Rep; 2017 Sep; 7(1):11621. PubMed ID: 28912586
[TBL] [Abstract][Full Text] [Related]
39. Circulating miR-18a in plasma contributes to cancer detection and monitoring in patients with gastric cancer.
Tsujiura M; Komatsu S; Ichikawa D; Shiozaki A; Konishi H; Takeshita H; Moriumura R; Nagata H; Kawaguchi T; Hirajima S; Arita T; Fujiwara H; Okamoto K; Otsuji E
Gastric Cancer; 2015 Apr; 18(2):271-9. PubMed ID: 24626859
[TBL] [Abstract][Full Text] [Related]
40. A Disintegrin and Metalloproteinase 8 as a Potential Blood Biomarker for Early Diagnosis of Gastric Cancer.
Chung HW; Kim JJ; Choi JI; Lee HR; Lim JB
Yonsei Med J; 2019 Aug; 60(8):713-719. PubMed ID: 31347325
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
